Edition:
United Kingdom

Gene Techno Science Co Ltd (4584.T)

4584.T on Tokyo Stock Exchange

916JPY
21 Aug 2018
Change (% chg)

¥-162 (-15.03%)
Prev Close
¥1,078
Open
¥1,058
Day's High
¥1,063
Day's Low
¥913
Volume
568,100
Avg. Vol
95,696
52-wk High
¥1,968
52-wk Low
¥539

Latest Key Developments (Source: Significant Developments)

Gene Techno Science signs collaborative research agreement with chromocenter
Monday, 30 Jul 2018 

July 30 (Reuters) - Gene Techno Science Co Ltd <4584.T>:Says it signed collaborative research agreement with chromocenter Inc..Says two entities mainly cooperate on establishment of cell lines construction related the basic technologies .  Full Article

Gene Techno Science commences phase III clinical trial for biosimilars in ophthalmology
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Gene Techno Science Co Ltd <4584.T>:Says it commenced the phase III clinical trial for biosimilars in ophthalmology, which is a joint work between the co and Senju Pharmaceutical Co Ltd .  Full Article

Gene Techno Science raises 301.9 mln yen via private placement
Monday, 27 Mar 2017 

Gene Techno Science Co Ltd <4584.T>:Says it raised 301.9 million yen via private placement.  Full Article

Gene Techno Science announces change of chairman and president
Tuesday, 14 Mar 2017 

Gene Techno Science Co Ltd <4584.T> :Says it appoints current president Masanari Kawaminami as new chairman, Masaharu Tani as new president, effective on April 1.  Full Article

Gene Techno Science signs joint research and development contract with Juntendo University
Monday, 27 Feb 2017 

Gene Techno Science Co Ltd <4584.T>: Says it signed a joint research and development contract for new immunosuppressive therapy with Juntendo University on Feb. 27 .Says contract period is from March 1, 2017 to Feb. 29, 2020.  Full Article

Gene Techno Science says business and capital alliance with JSR
Monday, 5 Dec 2016 

Gene Techno Science Co Ltd <4584.T>: says business and capital alliance with Japan-based firm JSR . Says two entities will cooperate manufacturing process development and manufacture of biosimilars and bio-drugs related pipeline, as well as manufacture of commercial biopharmaceuticals, etc .Says it to issue 343,407 shares (3.67 percent stake) to JSR on Dec. 22 via private placement for 500,000,592 yen.  Full Article

BRIEF-NanoCarrier says business and capital alliance with Gene Techno Science and Noritsu Koki

* Says it plans business and capital alliance with Gene Techno Science Co Ltd and Noritsu Koki Co Ltd, regarding biopharmaceutical related business